RFCA
ANGO icon

R&F Capital Advisors’s AngioDynamics ANGO Stock Holding History

R&F Capital Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$239K Buy
+13,756
New +$230K 0.06% 487

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
SAM
Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

R&F Capital Advisors's ANGO Position: Q1 2017 in Review

R&F Capital Advisors opened a new position in AngioDynamics (ANGO) in Q1 2017: 13,756 shares worth $239K. The stake represents 0.06% of the portfolio and ranks #487 among its holdings.

163 funds tracked by Wall St. Rank hold ANGO as of Q1 2017.

  • R&F Capital Advisors held 13,756 shares of AngioDynamics worth $239K as of Q1 2017.
  • AngioDynamics was a new R&F Capital Advisors position in Q1 2017.
  • AngioDynamics made up 0.06% of R&F Capital Advisors's portfolio in Q1 2017, its #487 holding.
  • 163 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.